Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Shutdown Plans For 2015: Same As 2013, But With More People

This article was originally published in The Pink Sheet Daily

Executive Summary

'Limited activities related to user fee funded programs' will continue if Congress does not pass a short-term funding measure by Oct. 1.


Related Content

FDA Shutdown Hangover Hurts Biosimilars, May Benefit Some ANDAs
Bayer’s Adempas Overcomes FDA Dosing Concerns To Win Approval
Pfizer’s Duavee Approved For Hot Flashes, Osteoporosis Prevention
FDA Will Not Review New Applications During Government Shutdown
FDA’s Shutdown Plan: Some User Fee Services Would Continue; Routine Inspections Would Not


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts